Hyaluronic acid is an acidic mucopolysaccharide, which was first isolated from bovine vitreous in 1934 by Meyer, Professor of Ophthalmology at Columbia University. With its unique molecular structure and physicochemical properties, hyaluronic acid shows a variety of important physiological functions in the body, such as lubricating joints, regulating the permeability of blood vessel wall, regulating the diffusion and operation of protein, water and electrolyte, promoting wound healing and so on.
Main purpose
Beauty function
Remove wrinkles
Shaping
Fill face
Hyaluronic Acid Powder, Sepiwhite Msh Powder, Snow White Powder, Alpha Arbutin Powder Xi'an Tian Guangyuan Biotech Co., Ltd. , https://www.tgybiotech.com
Â
Quick Detail:
Â
Product name
17α-Hydroxyprogesterone caproate
Other name
Hydroxyprogesterone caproate;17alpha-Hydroxyprogesterone caproate
CAS register number
630-56-8
Molecular formula
C27H40O4
Molecular weight
428.62
Appearance
White or almost white crystalline powder
Molecular structure
Â
Assay
98%
COA:
Â
Prodcut Name: Hydroxyprogesterone Caproate Standard:USP31
Â
Â
Â
Items
Standard
Resutls
Description
White or almost white crystalline powder, odorless
Conforms
Solubility
insoluble in water, solube in ether, slightly soluble in benzene
Conforms
Specific Optical Rotation
 +58°---+64° (1% chloroform Solution)
 60.3°
Melting Point
about 120 -124 ºC
123ºC
Water
 ≤0.1%
0.05%
Free N-Caproic Acid
 ≤0.58%
0.20%
Ordinary Impurities
 ≤2.0%
conforms
Residual Solvents
Methanol ≤ 3000PPM
1280PPM
Ethanol≤5000PPM
1500PPM
Dichloromethane ≤ 600PPM
80PPM
Assay
97.0%--103.0%
99.30%
Conclusion
Conforms to USP31
Â
Description;
To create a standardized formulation of 17P, the FDA approved Makena (KV Pharmaceutical Company), an orphan drug, on February 4, 2011. The approval was based on the premise that because 17P is a sterile injectable drug, a product approved according to FDA guidelines would provide "greater assurance of safety."10 Makena was approved via an accelerated approval process based on improvement in the proportion of women who delivered after 37 weeks of gestation. No controlled trials have demonstrated a direct clinical benefit of Makena, such as improvements in neonatal mortality and morbidity.
Â
The approved dosage of Makena is 250 mg (1 mL) weekly via IM injection, initiated at between 16 and 20 weeks of gestation and continued until week 37 or delivery, whichever occurs firs
Application;
Hydroxyprogesterone caproate injection is a man-made hormone of progestin. It is used in pregnant women to help lower the risk of giving birth too early ,This medicine is given only to pregnant women who are pregnant with one baby and who have had a preterm delivery of one baby in the past
Biochemical drugs with high clinical value are widely used in various ophthalmic operations, such as lens implantation, corneal transplantation and anti glaucoma surgery. It can also be used to treat arthritis and accelerate wound healing. When used in cosmetics, it can play a unique role in protecting the skin, keep the skin moist, smooth, delicate, tender and elastic, and play the role of anti wrinkle, anti wrinkle, beauty care and restoring the physiological function of the skin.
Model NO.: CAS; 630-56-8 Hydroxyprogesterone Caproate
Product Name: Hydroxyprogesterone Caproate
CAS Register Number: 630-56-8
Molecular Formula: C27h40o4
Molecular Weight: 428.62
Appearance: White or Almost White Crystalline Powder
Assay: 98%
Trademark: SMQ
Transport Package: Disguise Package
Specification: SGS
Origin: Shenzhen
HS Code: 235532699
Progesterone Hormones 17α-Hydroxyprogesterone Caproate Powder